---
figid: PMC7970416__fphar-11-600175-g006
figlink: pmc/articles/PMC7970416/figure/F6/
number: F6
caption: The sketch map demonstrated the mechanism involved in liraglutide alleviated
  hepatic steatosis and liver injury. GLP-1 agonist liraglutide could directly act
  on hepatic GLP-1R to stimulate the expression of PPARα through activating the PKA-AMPK
  signaling pathway. PPARα could stimulate the β-oxidation to relieve hepatic steatosis
  through stimulating the expression of CPT1a and decreasing that of ACC. Meanwhile,
  PPARα could also decrease the intracelluar ROS level to alleviate the liver injury.
  On the other hand, insulin could suppress the expression of GLP-1R to inhibit its
  downstream signaling, while the administration of GLP-1 could recover the insulin
  aggravated hepatic steatosis.
pmcid: PMC7970416
papertitle: Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats
  via a GLP-1R Dependent AMPK Pathway.
reftext: Rui Zhou, et al. Front Pharmacol. 2020;11:600175.
pmc_ranked_result_index: '29259'
pathway_score: 0.9616324
filename: fphar-11-600175-g006.jpg
figtitle: Sketch map demonstrated the mechanism involved in liraglutide alleviated
  hepatic steatosis and liver injury
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7970416__fphar-11-600175-g006.html
  '@type': Dataset
  description: The sketch map demonstrated the mechanism involved in liraglutide alleviated
    hepatic steatosis and liver injury. GLP-1 agonist liraglutide could directly act
    on hepatic GLP-1R to stimulate the expression of PPARα through activating the
    PKA-AMPK signaling pathway. PPARα could stimulate the β-oxidation to relieve hepatic
    steatosis through stimulating the expression of CPT1a and decreasing that of ACC.
    Meanwhile, PPARα could also decrease the intracelluar ROS level to alleviate the
    liver injury. On the other hand, insulin could suppress the expression of GLP-1R
    to inhibit its downstream signaling, while the administration of GLP-1 could recover
    the insulin aggravated hepatic steatosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GLP1R
  - PRKACG
  - PRKAR1A
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKAR1B
  - MFAP1
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - PPARA
  - CPT1A
  - ACACB
  - ACACA
  - ATP
  - AMP
  - Hepatic steatosis
  - Liver injury
genes:
- word: GLP-1R
  symbol: GLP-1R
  source: hgnc_alias_symbol
  hgnc_symbol: GLP1R
  entrez: '2740'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: PPARA
  symbol: PPARA
  source: hgnc_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: CPT1A
  symbol: CPT1A
  source: hgnc_symbol
  hgnc_symbol: CPT1A
  entrez: '1374'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
chemicals:
- word: ATP
  source: MESH
  identifier: D000255
- word: AMP
  source: MESH
  identifier: D000249
diseases:
- word: Hepatic steatosis
  source: MESH
  identifier: D005234
- word: Liver injury
  source: MESH
  identifier: D056486
figid_alias: PMC7970416__F6
redirect_from: /figures/PMC7970416__F6
figtype: Figure
---
